Product Images Dapsone

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Dapsone NDC 10135-654 by Marlex Pharmaceuticals Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Dapsone is issued on prescription in tablets of 25 and 100 mg for oral use. - dapsone 01

Dapsone is issued on prescription in tablets of 25 and 100 mg for oral use. - dapsone 01

PRINCIPAL DISPLAY PANELNDC 10135-0654-30DapsoneTablets, USP25 mg30 TABLETSRx Only - dapsone 02

PRINCIPAL DISPLAY PANELNDC 10135-0654-30DapsoneTablets, USP25 mg30 TABLETSRx Only - dapsone 02

NDC 10135-0654-30 is a USP Dapsone tablet that contains 25 milligrams of the drug. The proper dosage should be read in the accompanying literature. Additionally, the tablets should be stored in a tight light-resistant container at a temperature between 20 to 25 degrees Celsius. The tablets might also be stored at a controlled room temperature between 15 to 30 degrees Celsius. The drug should be kept out of reach of children. Marlex Pharmaceuticals produced and distributed this drug, as denoted by the text.*

PRINCIPAL DISPLAY PANELNDC 10135-0654-01DapsoneTablets, USP25 mg100 TABLETSRx Only - dapsone 03

PRINCIPAL DISPLAY PANELNDC 10135-0654-01DapsoneTablets, USP25 mg100 TABLETSRx Only - dapsone 03

NDC 10135-0654-01 is a drug manufactured and distributed by Marlex Pharmaceuticals, Inc. It contains Dapsone, USP in tablet form. The usual dosage information is available in the accompanying literature. The drug should be stored between 20° to 25°C (68° to 77°F), with some excursions permitted between 15° to 30°C (59° to 8°F), as per the USP Controlled Room Temperature guidelines. The drug should be kept out of the reach of children and dispensed in a tight, light-resistant container. The text also denotes that the drug requires a prescription.*

PRINCIPAL DISPLAY PANELNDC 10135-0655-30DapsoneTablets, USP100 mg30 TABLETSRx Only - dapsone 04

PRINCIPAL DISPLAY PANELNDC 10135-0655-30DapsoneTablets, USP100 mg30 TABLETSRx Only - dapsone 04

NDC 10135-0655-30 is a medication that comes in a tablet form containing 100mg of Dapsone USP. The usual dosage and instructions for use can be found in the accompanying literature. Store the tablets at 20° to 25°C (68° to 77°F). It is recommended to keep the medication in a tight light resistant container and out of the reach of children. This medication is manufactured and distributed by Marlex Pharmaceuticals, Inc.*

PRINCIPAL DISPLAY PANELNDC 10135-0655-01DapsoneTablets, USP100 mg100 TABLETSRx Only - dapsone 05

PRINCIPAL DISPLAY PANELNDC 10135-0655-01DapsoneTablets, USP100 mg100 TABLETSRx Only - dapsone 05

This is a medication label for Dapsone tablets with the NDC code 10135-0655-01. Each tablet contains 100mg of Dapsone, and the recommended dosage and storage instructions are included. The medication should be stored in a tight, light-resistant container at a controlled room temperature between 20° to 30°C (68° to 86°F), with excursions permitted. Additionally, the label includes a warning to keep the medication and all drugs out of the reach of children. The tablets are manufactured for/distributed by Marlex Pharmaceuticals and the label is dated May 2018.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.